Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Global Brain Corporation is an independent venture capital firm founded in January 1998 and headquartered in Tokyo, Japan. The firm has established itself as one of Japan's largest venture capital entities, managing over $2.7 billion in assets across more than 24 funds. Since its inception, Global Brain has executed over 1,200 deals, investing more than $1.4 billion into a diverse array of startups.
Global Brain's mission centers on supporting startups through extensive hands-on assistance and fostering open innovation with large corporations. The firm has facilitated 41 IPOs and 82 M&As, showcasing its effectiveness in nurturing companies to successful exits. Its portfolio includes approximately 450 active companies, reflecting a broad investment strategy that spans multiple sectors and stages of development.
In addition to its flagship funds, Global Brain manages corporate venture capital (CVC) funds for over 20 major Japanese enterprises, enhancing its reach and impact within the startup ecosystem. The firm operates from its Tokyo base while maintaining a global investment strategy that includes significant interests in North America, Europe, and Asia.
Global Brain Corporation invests across a wide range of sectors, including AI, Climate Tech, Healthcare, FinTech, Cloud/SaaS, Education, Robotics, and Space. The firm targets startups at various stages, from seed to growth equity, with a particular emphasis on companies that demonstrate the potential to become global leaders. This diverse sector focus allows Global Brain to adapt to emerging trends and technologies, ensuring its portfolio remains relevant and competitive.
The firm’s investment strategy is geographically diverse, concentrating on Japan while also extending its reach to North America, Europe, and Asia. Global Brain seeks to identify and support innovative startups that align with its vision of fostering open innovation and collaboration with large corporations. The firm values founders who are committed to their vision and possess the capability to scale their businesses effectively.
Global Brain Corporation maintains an active portfolio of around 450 companies, showcasing its commitment to diverse and innovative startups. Notable portfolio companies include:
This diverse portfolio reflects Global Brain's strategic focus on sectors that are poised for growth and innovation, particularly in technology and healthcare.
Brian Flucht: Partner, US Division Head. Brian has extensive experience in venture capital and has led numerous successful investments in technology startups.
Akifumi Chris Takigawa: Director, Investment Group. Akifumi specializes in identifying high-potential startups and has a strong background in technology investments.
Ryo Kiyofuji: Director, Investment Group. Ryo brings expertise in market analysis and strategic investment planning.
Miku Yoshio: General Partner, Investment Group. Miku has a proven track record in scaling startups and has been instrumental in several successful exits.
Yu Kadowaki: Director, Platform Group. Yu focuses on enhancing the value of portfolio companies through operational support and strategic partnerships.
To pitch Global Brain Corporation, founders should submit their proposals through the firm's website. The pitch deck should include a clear overview of the business model, market opportunity, and growth strategy. While specific response times are not disclosed, it is advisable to follow up after a few weeks if no response is received. Warm introductions can enhance the chances of getting noticed, so leveraging connections within the industry is beneficial.
Global Brain operates the XLIMIT accelerator program, designed to assist startups in reaching Series A funding. This program provides selected companies with approximately 10 million JPY in funding, along with mentoring and networking opportunities with industry experts and potential investors.
In recent developments, Global Brain Corporation has partnered with Techstars to establish a $200 million cross-border fund aimed at fostering innovation between the US and Japan. This partnership enhances Global Brain's ability to support startups in both regions.
Additionally, the firm recently closed its Global Brain Flagship Fund IX (GB-IX) at approximately JPY 32.48 billion (over $215 million), focusing on IT and DeepTech sectors. This fund will further bolster their investment capabilities and support for emerging startups.
What are Global Brain's investment criteria?
Global Brain invests in startups across various sectors, including AI, Climate Tech, Healthcare, and FinTech. They focus on companies at seed to growth equity stages, particularly those with the potential to become global leaders.
How can I pitch to Global Brain?
Founders can pitch to Global Brain through their website. It is recommended to include a clear business model, market analysis, and growth strategy in the pitch deck.
What makes Global Brain different from other VCs?
Global Brain emphasizes hands-on assistance and open innovation, providing extensive mentoring and networking opportunities with industry experts and potential investors.
What is Global Brain's geographic scope?
The firm primarily focuses on Japan but also invests in North America, Europe, and Asia, leveraging its global reach to support startups.
What is the typical check size for investments?
While specific check sizes are not disclosed, Global Brain invests across various stages, indicating flexibility in funding amounts based on the startup's needs and growth potential.
What kind of post-investment support does Global Brain provide?
Global Brain offers extensive hands-on assistance, mentoring, and access to a network of industry experts and potential investors to help portfolio companies grow and succeed.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.